Swiss National Bank - AIMMUNE THERAPEUTICS INC ownership

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 74 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 6.67 and the average weighting 1.3%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$3,313,000
+113.7%
96,174
+3.7%
0.00%
+200.0%
Q2 2020$1,550,000
+46.0%
92,774
+25.9%
0.00%0.0%
Q1 2020$1,062,000
-55.9%
73,674
+2.5%
0.00%
-50.0%
Q4 2019$2,406,000
+65.4%
71,874
+3.5%
0.00%0.0%
Q3 2019$1,455,000
+0.6%
69,4740.0%0.00%0.0%
Q2 2019$1,446,000
-11.8%
69,474
-5.3%
0.00%0.0%
Q1 2019$1,640,000
+2.1%
73,374
+9.2%
0.00%0.0%
Q4 2018$1,607,000
-8.6%
67,174
+4.2%
0.00%0.0%
Q3 2018$1,759,000
+1.4%
64,4740.0%0.00%0.0%
Q2 2018$1,734,000
-15.5%
64,4740.0%0.00%
-33.3%
Q1 2018$2,052,000
+33.7%
64,474
+58.9%
0.00%
+50.0%
Q4 2017$1,535,000
+67.4%
40,574
+9.7%
0.00%
+100.0%
Q3 2017$917,000
+20.7%
36,9740.0%0.00%0.0%
Q2 2017$760,000
-5.4%
36,9740.0%0.00%0.0%
Q1 2017$803,000
+24.7%
36,974
+17.5%
0.00%0.0%
Q4 2016$644,000
+36.4%
31,4740.0%0.00%0.0%
Q3 2016$472,000
+38.4%
31,4740.0%0.00%0.0%
Q2 2016$341,000
+16.8%
31,474
+41.3%
0.00%0.0%
Q1 2016$292,000
+19.2%
22,274
+67.5%
0.00%0.0%
Q4 2015$245,00013,3000.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,295,712$47,524,0003.98%
Samsara BioCapital, LLC 232,571$3,354,0001.93%
Eventide Asset Management 3,851,000$55,531,0001.80%
Burrage Capital Management LLC 112,546$1,609,0001.58%
Avidity Partners Management LP 408,000$5,883,0000.81%
RICE HALL JAMES & ASSOCIATES, LLC 982,484$14,167,0000.79%
Bullseye Asset Management LLC 43,374$626,0000.75%
Nantahala Capital Management 1,005,302$14,496,0000.54%
ARMISTICE CAPITAL, LLC 600,000$8,652,0000.54%
Values First Advisors, Inc. 27,042$389,9470.47%
View complete list of AIMMUNE THERAPEUTICS INC shareholders